Biosergen - Board of Directors

Board Of Directors


Torsten Goesch MD, MBA, PhD, Chairman of the Board since 2015	Lena Degling Wikingsson, MD, Board member since 2021	Achim Kaufhold MD, Board Member since 2021	Marianne Kock MSc, MBA, Board member since 2021
Professional experience	Professional experience	Professional experience	Professional experience
Dependent in relation to the company, independent in relation to its senior executives and major shareholders. Dr. Torsten Goesch has been Director of Rosetta Capital’s secondary life science investments since 2002 Has served as the General Manager for the German Speaking Countries at Biogen from 1997-1999 Commercial Head of Merck KGaA’s worldwide generics drug business Merck Generics	Independent in relation to the company, to its senior executives and major shareholders. Currently serves as CEO of Dilafor Board member of the Swedish companies, Simplexia, XNK Therapeutics and Alzinova. Former CEO of Independent Pharmaceutica and Avaris Non-executive Director of Next Cell Pharma, Avaris and Eurocine Vaccines	Independent in relation to the company, to its senior executives and major shareholders. Currently serves as CMO of Hansa Biopharma. Has previously served as CEO of Affitech and Pharmexa (both companies merged) CMO of companies such as Basilea Pharmaceutica, Chiron (acquired by Novartis) and Berna Biotech (now Johnson & Johnson)	Independent in relation to the company, to its senior executives and major shareholders. Currently serves as General Manager at Ferring Pharmaceuticals’ IPC Development Unit in Copenhagen. Board member of Ferring Pharmaceutical (DK), Syntese (DK), Izvarino Pharma (Rus), NanoPharm (Rus) and Asarina (SE) Previously, board member of Fertin Pharma (DK), Bionor Pharma (NO), Egalet (DK), Forward Pharma (DK) and Gastrotech Pharma (DK)
Educational background	Educational background	Educational background	Educational background
Doctor of Medicine (MD) and Ph.D. from Heinrich Heine University Düsseldorf Master of Management (MBA) from Northwestern University’s J.L. Kellogg Graduate School of Management	Lena Degling Wikingsson holds a Ph.D. in Pharmaceutical Science and a Master of Science (MSc) in Pharmacy, both from Uppsula University, Sweden	Doctor of Medicine from the University of Cologne and holds a professorship in Medical Microbiology and Infectious Diseases at the University of Aachen, Germany	Master’s degree in Pharmacy from Danish University of Pharmacy Executive Master’s degree in Business Administration from Scandinavian International Management Institute


Henrik Moltke MSc, Board Member since 2021	Hanne Mette Dyrlie Kristensen, MSc, MBA, Board member since 2021	Mattias Klintemar MBA, Board Member since 2021
Professional experience	Professional experience	Professional experience
Independent in relation to the company, to its senior executives and major shareholders. Currently serves as CFO of FluoGuide A/S (Nasdaq First North Growth Market Stockholm) Board member at Hartmanns A/S Board member at Initiator Pharma Former CFO at Oncology Venture A/S (Nasdaq First North Growth Market Stockholm)	Independent in relation to the company, to its senior executives and major shareholders. Currently serves as CEO, The Life Science Cluster Founder, Oslo Life Science Advisors AS Has served as Special advisor, responsible for Life Sciences / Health, Invest In Norway & Innovation Norway Member of the Board of Regionale Forskningsfond, RFF Viken CEO of Targovax AS	Dependent in relation to the company, independent in relation to its senior executives and major shareholders. Currently serves as Director of Investments at Östersjöstiftelsen Has served as CEO at Morphic Technologies AB, CFO at Hexaformer Chairman of the board at Dilafor Board member at Oatly, Phoniro, Pharmanest AB, Cell impact and Axelar
Educational background	Educational background	Educational background
Msc (Econ) – cand.merc., Strategy and International Economics at Copenhagen Business School	Master of Technology Management (MTM) from Norwegian University of Science and Technology and MIT, Sloan School of Management, Boston Cand. Scient. in Chemistry, specialization in Biochemistry at University of Oslo	Bachelor of Business Administration (B.B.A.), Accounting and Finance from Karlstad Universit